Management
Consulting

Our consulting Service includes:
– Identify innovative idea and/or seeds and their combination from medical viewpoint.
– Create & adjust medical values from the innovative idea or seeds.
– Design POC study and clinical studies to submit to health authorities for possible registration.
– Connect at the global level for Matching, Strategic Alliance, Collaboration and Partnering.
– Practice based on the Regulatory Science (regulatory strategy and risk-benefit maximization particularly from medical viewpoint).
– Develop Project managers to best manage quality and resource. Develop changed mindset and skills for younger generation through connecting people, co-evolution, and mentoring.

BIC has a strong focus on pharmaceutical business development. Our consultants all have decades of experience, and proven track record in in-and out-licensing in the areas of pharmaceutical, biotechnology, consumer healthcare and related industries. We can therefore provide you with a comprehensive insight into your needs.

Our services include:
In-Licensing
(Identify, Evaluate, Negotiate & Deal-closure or develop strategic partnership)

Out-Licensing
(Identify, Evaluate, Negotiate & Deal-closure or develop strategic partnership)

Alliance management

Mergers and Acquisitions (M&A)

Due diligence
(Scientific and Commercial)

Drug Discovery Technology Consulting

Drug discovery technologies play a vital role in the growth of the entire pharmaceutical industry as they are the key contributors in the swift introduction of blockbusters and innovative drugs, which is the most important aspect for the pharmaceutical companies. Read more.. The applications of excellent technologies in the introduction of drugs for diverse diseases such as cancer, CVD, CNS disorders such as Parkinson’s and Alzheimer’s and other serious chronic diseases have created significant opportunities for the market growth in the future. The slow growth of the introduction of new blockbuster drugs is a major concern which the drug development companies are catering to by using top technologies.

Biologics and Next Generation of Antibody Consulting

The competitive benefits of identifying and addressing new therapeutic targets continue to provide incentives for new target selection and monoclonal antibody identificationprograms.Read more.. Genetic engineering methods and novel ‘host cell’ production systems are being used to optimize and modify functions of monoclonal antibodies. Proprietary platforms using novel methods have been widely licensed to many of the major players in the biopharmaceutical industry. The newest technologies for modifying antibodies involve redesigning the entire shape of the antibody molecules. Alternative antibody formats produced naturally by species such as sharks and camels have provided inspiration for a wide variety of new target-binding molecules, with new abilities and properties not found in human antibodies. We analyze the strengths and limitations of the biopharma marketplace, important research avenues being pursued, and an overview of recent R&D developments. We also provides assessment of the contribution of biopharma to the management of major diseases, identifies possible avenues for new product development, and examines national and regional markets in terms of comparative importance and developing opportunities.

We offer customized consultancy services in the following categories:

– Antibody design, production and development
– Recombinant DNA/molecular biotechnology
– Protein/biochemical engineering
– Biotherapeutics
– Assay and cell display technologies
– Bio-analytical and protein-analytical R&D, and analytical chemistry
– Process development
– Preclinical/clinical research and development
– Immunobiology and immunogenicity testing
– Pharmacovigilance
– Business and alliance development
– Marketing and licensing
– Biosimilars
– Contract manufacturing and research organizations
– Regulatory affairs, pharmaceutical and patent law

BIC offers a holistic approach to biotech and pharmaceutical clients seriously considering either Japan entry or business expansion into Asian markets. Our strengths are in-depth knowledge to deal with complex business reality and customized hands-on support. Our team’s  solid background as pharma executives make a difference from a kind of framework application consulting.

Our one-stop consulting covers strategic congruence from product potential analysis, fast market access, market strategy through sophisticated channel management. We also have a cross-functional network for medical, regulatory & quality, Human Resources, finance and executive search.

Meet our pharma leadership team